We look forward to sharing additional Phase 1/2 data next week at the Muscular Dystrophy Association's annual meeting and ...

BNY Mellon Small/Mid Cap Growth Fund (Class A shares at NAV) outperformed its benchmark, the Russell 2500 Growth Index, during the fourth quarter of 2025.